Advantages of the CBA mouse in leukemogenesis research

Blood Cells, Molecules, and Diseases

Volumn 25, Issue 1, 1999, Pages 38-45

  Rithidech, K Noy ^a   Cronkite, E P ^b   Bond, V P ^c  

^a STONY BROOK UNIVERSITY   (United States)

^b BROOKHAVEN NATIONAL LABORATORY   (United States)

^c WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Benzene; Cytogenetics; Leukemogenesis; Radiation

Indexed keywords

BENZENE;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHROMOSOME DAMAGE; CYTOGENETICS; HIGH RISK PATIENT; LEUKEMOGENESIS; MOUSE; MYELODYSPLASTIC SYNDROME; NONHUMAN; PRIORITY JOURNAL; RADIATION CARCINOGENESIS; SPLENOMEGALY;

ANIMALIA;

EID: 0033081569     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1006/bcmd.1999.0225     Document Type: Article

References (69)

1. Upton AC, Furth J, Christenberry KW. Late effects of thermal neutron irradiation in mice. Cancer Res 14:682-688, 1954.
2. Haran-Ghera N, Kotler M, Meshorer A. Studies on leukemia development in the SJL/J strain of mice. J Natn Cancer Inst 39:653-656, 1967.
3. Major RI, Mole RH. Myeloid leukemia in x-ray irradiated CBA mice. Nature, 272:455-456,1978.
4. Hayata I. Leukemogenesis and chromosomal abnormalities: Experimental animals. Acta HemaTol Jpn 48:1857-1863, 1983.
5. Di Majo V, Coppola M, Rebessi S, et al. Dose response relationship of radiation-induced harderian gland tumors and myeloid leukemia of the CBA/Cne mouse. J Natl Cancer Inst 77:933-939, 1986.
6. Cronkite EP, Bond VP. Radiation leukemia-prediction of low-dose effects. National Cancer Institute Rep. Contract Y01-CO-10712, 1988.
7. Johnson JR, Myers DK, Jackson JS, et al. Relative biological effectiveness of tritium for induction of myeloid leukemia in CBA/H mice. Radiat Res 144:82-89, 1995.
8. Cronkite EP, Drew RT, Inoue T, Hirabayashi Y, Bullis JE. Hematoxicity and carcinogenicity of inhaled benzene. Env Health Persp 82:97-108, 1989.
9. Rithidech K. Identification of chromosome and gene changes during the development of radiation-and benzene-induced murine myeloid leukemia", A Report to DOE Contract DE-AC02-76CH00016, 1996.
10. Nishioka Y. The origin of common laboratory mice. Genome 38:1-7, 1995.
11. Rithidech K, Bond VP, Cronkite EP, Thompson MH. A specific chromosomal deletion in murine leukemic cells induced by radiation with different qualities. Exp Hematol 2:427-431, 1993.
12. Farris GM, Everitt JI, Irons RD, Popp JA. Carcinogenicity of inhaled benzene in CBA mice. Fund Appl Toxicol 20:503-507, 1993.
13. Boggs DR. Clonal origin of leukemia site of origin in the stem cell hierarchy and the significance of chromosomal changes. Blood Cells 7:205-215, 1981.
14. Ueda T, KIta K, Kagawa D, et al. Acute leukemia with two cell populations of lymphoblasts and monoblasts. Leukemia Res 8:63-69, 1984.
15. Das Gupta A, Advant SH, Nair CN, et al. Acute leukemia with coexpression of lymphoid and myeloid phenotypes. Hematol Oncol 5:189-196, 1987.
16. Schmitt-Graff A, Jurgen H, Reifenhauser A, Schwamborn D, Gobel U. Childhood biphenotypic leukemia:detection of mixed lymphoid and myeloid populations in bone marrow specimens. Human Pathology 19:651-656, 1988.
17. Keinanen M, Griffin JD, Bloomfield CD, MachNiki J, De La Chapelle A. Clonal chromosomal abnormalities showing multiple-cell-lineage involvement in acute myeloid leukemia. The New England J Med 318(18):1153-1158, 1988.
18. Cuneo A, Michaux J-L, Ferrant A, et al. Correlation of cytogenetic patterns and clinicobiological features in adult acute myeloid leukemia expressing lymphoid markers. Blood 79(3):720-727, 1992.
19. Bold DH, Kopecky KJ, Head D, GEhly G, Radich JP, Appelbaum FR. Expression of myeloid antigens by blast cells in acute lymphoblastic leukemia of adults. The Southwest oncology group experience. Leukemia 8(12):2118-2126, 1994.
20. Lim SH, Culligan D, Couzens S, Fisher J, John S, Pollard P. Molecular evidence for a common leukemic progenitor in acute mixed lymphoid and myeloid leukemia. British J Haematol 92: 131-133, 1996.
21. Khalidi HS, Medeiros LJ, Chang KL, Brynes RK, Slovak ML, Arber DA. The immunophenotype of adult acute myeloid leukemia: High frequency of lymphoid antigen expression and comparison of immunophenotype, French-American-British classification, and karyotypic abnormalities. Amer J Clin Path 109(2):211-220, 1997.
22. Hayata I, Seki M, Yoshida K, Hirashima F, Sado F, Yamagiwa J, Ishihara T. Chromosomal aberrations observed in 52 mouse myeloid leukemias. Cancer Res 43:367-373, 1983.
23. Breckon G, Silver ARJ, Cox R. Consistent chromosome changes in radiation-induced murine leukemias. In Brandham P.E., Bennet M.D. (eds) Kew Chromosome Conference III. London: HMSO pp. 179-184, 1988.
24. Trakhtenbrot L, Krauthgamer R, Resnitsky P, Haran-Ghera N. Deletion of chromosome 2 is an early event in the development of radiation-induced myeloid leukemia in SJL/J mice. LeukeMia 2:545-550, 1988.
25. Bouffler SD, Breckon G, Cox R. Chromosomal mechanisms in murine radiation acute myeloid leukemogenesis. Carcinogenesis 17:655-659, 1996.
26. Bouffler SD, Meijne EIM, Huiskamp R, Cox R. Chromosomal abnormalities in neutron-induced acute myeloid leukemias in CBA/H mice. Radiat Res 146:349-352, 1996.
27. Rithidech K, Dunn JJ, Bond VP, Gordon CR, Cronkite EP. Characterization of genetic instability in radiation and benzene induced murine acute leukemia. Submitted to Mutat Res 1998.
28. Smith MT, Zhang L, Wang Y et al. Increased translocations and aneusomy in chromosomes 8 and 21 among workers exposed to benzene. Cancer Res 58:2176-2181, 1998.
29. Irons RD, Neptun DA, Pfeifer RW. Inhibition of lymphocytes transformation and microtubule assembly by quinone metabolites of benzene: Evidence for a common mechanisms. J ReticuloenDothel Sco 30:359-372, 1981.
30. Eastmond DA, Rupa DS, Hasegawa LS. Detection of hyperdiploidy and chromosome breakage in interphase human lymphocytes following exposure to benzene metabolite hydroquinone using multicolor fluorescence in situ hybridization with DNA probes. Mutat Res 322(1):9-20, 1994.
31. Zhang L, Venkatesh P, Creek, Smith MT. Detection of 1,2,4-benzenetriol induced aneuploidy and microtubule disruption by fluorescence in situ hybridization and immunocytochemistry. Mutat Res 320(4):315-327, 1994.
32. Bonomi R, Le Coniat M, Berger R. Is trisomy 4 a secondary chromosomal abnormality in acute myeloblastic leukemia. Cancer Genet Cytogenet 79(2):186-187, 1995.
33. Reddy KS, Sulcova V. c-myc amplification in a preleukemic patient with trisomy 4 and double minutes: Review of the unique coexistence of these two chromosome abnormalities in acute myelogenous leukemia. Cancer Genet Cytogenet 95(2):206-209, 1997.
34. Keung YK, Kaplan B, Douer D. Biphenotypic M0 acute myeloid leukemia with trisomy 4. Leuk Lymphoma 14(1-2):181-184, 1994.
35. Gull GM, Howe DJ, Stack-Dunne M, Phillips MJ, Johnson SA. Tetrasomy of chromosome 8 in a patient with acute myeloid leukemia. Leuk Lymphoma 19(3-4):355-358, 1995.
36. Shao J, Zhang L, Semenza JC, BEach B, Smith MT. Tetrasomy 8 detected by interphase cytogenetics in a child with acute lymphocytic leukemia. Cancer Genet Cytogenet 92(2):135-140, 1996.
37. Amiel A, Elis A, Manor Y, Tangi I, Fejgin M, Lishner M. Fluorescence in situ hybridization (FISH) for the detection of trisomy 8 in acute myeloblastic leukemia. Leuk Lymphoma 23(5-6): 603-607, 1996.
38. Cuneo A, Bigoni R, Roberti MG et al. Detection and monitoring of trisomy 8 by fluorescence in situ hybridization in acute myeloid leukemia: A multicentric study. Haematologica 83(1):21-26, 1998.
39. Collins KJ. Acute myeloid leukemia in patients with trisomy 21. J Paediatr Child Health 31(1): 57, 1995.
40. Wei CH, Yu IT, Tzeng CH et al. Trisomy 21 in acute myeloid leukemia. Cancer Genet CytoGenet 86(2):177-180, 1996.
41. Berger R. Acute lymphoblastic leukemia and chromosome 21. Cancer Genet Cytogenet 94(1): 8-12, 1997.
42. Wiener F, Spira J, Ohno S, Haran-Ghera N, Klein G. Chromosome changes (Trisomy 15) in murine T-cell leukemia induced by 7,12-dimethylbenz(a)anthracene (DMBA). Int J Cancer 22: 447-453, 1978.
43. Wiener F, Ohno S, Spira J, Haran-Ghera N, Klein G. Cytogenetic mapping of the trisomic segment of chromosome 15 in murine T-cell leukemia. Nature 275:658-660, 1978.
44. Spira J, Weiner F, Babonits M, Gamble J, Miller J, Klein G. The role of chromosome 15 in murine leukemogenesis. I. Contrasting behavior of the tumor vs. Normal parent-derived chromosome no. 15 in somatic hybrids of varying tumorigenicity. Int J Cancer 28:785-789, 1981.
45. Mouse Genome Informatics (MGI) Resource, Mouse Genome Informatics, The Jackson Laboratory, Bar Harbor, Maine. World Wide Web (URL:htttp//www.informatics.jax.org/) December, 1998.
46. Mitelman, F, Mertens F, Johanson B. A breakpoint map of recurrent chromosomal rearrangements in human neoplasia. Nature Genet 15:417-474, 1997.
47. Singer B, Kusmierek JT. Chemical carcinogenesis. Ann Rev Biochem 51:655-693, 1982.
48. Valentino JL, Lee ST, Seaton MJ, Reduction of benzene metabolism and toxicity in mice that lack CYP2E1 expression. Toxicol Appl Pharm a Col 141:205-213, 1996.
49. Featherstone MS, Baron A, Gaunt SJ, Mattei M-G. Hox5.1 defines a homeobox-containing gene locus on mouse chromosome 2. Proc Natl Acad Sci 85:4760-4764, 1988.
50. Glaser T, Lane J, Housman D. A mouse model of the aniridia-Wilms tumor deletion syndrome. Science 249:823-827, 1990.
51. Boultwood J, Breckon G, Birch D, Cox R. Chromosomal localization of murine interleukin-1a and b genes. Genomics 5:481-485, 1989.
52. Blatt C, Sachs L. Deletion of a homeobox gene in myeloid leukemias with a deletion of chromosome 2. Biochem Biophysic Res Comm 156:1265-1270, 1988.
53. Lawrence HJ, Largman C. Homeobox genes in normal hematopoiesis and leukemia. Blood 80(10):2445-2453, 1992.
54. Silver A, Boultwood J, Breckon G, et al. Interleukin-1b gene deregulation associated with chromosomal rearrangement: A candidate initiating event for murine radiation-myeloid leukemogenesis. Mol Carcinogenesis 2:226-233, 1989.
55. King-Underwood L, Renshaw J, Pritchard-Jones K. Mutations in the Wilms' Tumor gene WT1 in leukemia. Blood 87(6):2171-2179, 1996.
56. Rithidech K, Bond VP, Cronkite EP, Thompson MH, Bullis, JB. Hypermutability of mouse chromosome 2 during the development of x-ray-induced murine myeloid. Proc Natl Acad Sci 92:1152-1156, 1995.
57. Bouffler SD, Meijne EIM, Morris DJ, Papworth D. Chromosome 2 hypersensitivity and clonal development in murine radiation acute myeloid leukemia. Int J Radiat Biol 72(2):181-189, 1997.
58. Djalali M, Adolph S, Steinbach P, Winking H, Hamester H. A comparative mapping study of fragile sites in the human and murine genomes. Hum Genet 77:157-162, 1987.
59. Elder F.F.B., Robinson TJ. Rodent common fragile sites: Are they conserved? Evidence from mouse and rat. Chromosoma (Berl) 97:459-464, 1989.
60. Siracusa LD, Abbott CM, Morgan JL, Zuber AR, Pomp D, Peters J. Mouse chromosome 2. Mamm Genome 7:S28-S44, 1997.
61. Hinoda Y, Itoh H, TAkakashi T, et al. Myelodysplastic syndrome in a patient with a unique constitutional chromosome abnormality t(2;11)q31;p13). Int J Hematol 56(1):95-97, 1992.
62. Quintell N, Lebo R, Varmus H, et al. Identification of a human gene (HCK) that encodes a protein-tyrosine kinase and is expressed in hemopoietic cells. Mol Cell Biol 7(6):2267-2275, 1987.
63. Asimokopoulos FA, White NJ, Nacheva EP, Green AR. The human CD40 gene lies within chromosome 20q deletions associated with myeloid malignancies. Br J Hematol 92:127-130, 1996.
64. Asimokopoulos FA, White NJ, Nacheva EP, Green AR. Molecular analysis of chromosome 20q deletions associated with myeloproliferative disorders and myelodysplasia syndromes. Blood 84(9):3096-3094, 1994.
65. Roulston D, Espinosa R, Stoffel M, Bell GI, Le Beau MM. Molecular genetics of myeloid leukemia: Identification of the commonly deleted segment of chromosome 20. Blood 82(11):3424-3429, 1993.
66. Boutwood J, Lewis S, Wainscoat JS. The 5q-syndrome. Blood 84:3253-3260, 1994.
67. Le Beau MM, Espinosa R, Davis EM, Eisenbart JD, Larson RA, Green ED. Cytogenetic and molecular delineation of a region of chromosome 7 commonly deleted in malignant myeloid disorders. Blood 88:1930-1935, 1996.
68. Crowell RE, Gilliland FD, Temes RT, et al. Detection of trisomy 7 in nonmalignant bronchial epithelium from lung cancer patients and in individuals at risk for lung cancer. Cancer Epid e miol Biomarkers Prev 5(8):631-637, 1996.
69. Lechner JF, Neft RE, Gillialand FD, et al. Individuals at high risk for lung cancer have airway epithelial cells with chromosome aberrations frequently found in lung tumor cells. In Vivo 12(1):23-26, 1998.